Professional
Added to YB: 2025-02-05
Pitch date: 2024-12-31
IQV [bullish]
IQVIA Holdings Inc.
+11.79%
current return
Author Info
No bio for this author
Company Info
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Market Cap
$38.5B
Pitch Price
$198.82
Price Target
N/A
Dividend
N/A
EV/EBITDA
16.87
P/E
30.92
EV/Sales
3.26
Sector
Life Sciences Tools and Services
Category
value
Oakmark U.S. Large Value Strategy Portfolio Holding: IQVIA Holdings Inc.
IQV: Stock down on reduced near-term R&D outlook due to program cancellation & 2 large trial delays to 2025. Tech & analytics segment growth recovering as expected. Headwinds should abate by 2025. Cheap at mid-teens multiple of normal earnings power.
Read full article (1 min)